These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29035099)

  • 1. Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults.
    Kou H; Jin X; Gao D; Ma R; Dong X; Wei J; Wang X
    Clin Exp Hypertens; 2018; 40(1):8-15. PubMed ID: 29035099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of growth differentiation factor-15 with left ventricular hypertrophy in hypertensive patients.
    Xue H; Fu Z; Chen Y; Xing Y; Liu J; Zhu H; Zhou X
    PLoS One; 2012; 7(10):e46534. PubMed ID: 23071585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.
    Hanatani S; Izumiya Y; Takashio S; Kojima S; Yamamuro M; Araki S; Rokutanda T; Tsujita K; Yamamoto E; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    Heart Vessels; 2014 Mar; 29(2):231-7. PubMed ID: 23525862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.
    Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE
    Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy is associated with increased sirtuin level in newly diagnosed hypertensive patients.
    Duman H; Bahçeci I; Çinier G; Duman H; Bakırcı EM; Çetin M
    Clin Exp Hypertens; 2019; 41(6):511-515. PubMed ID: 30230925
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in circulating activin A, GDF-15, TGF-beta3 and MMP-2, -3, and -9 during one year of left ventricular reverse remodelling in patients operated for severe aortic stenosis.
    Bjørnstad JL; Neverdal NO; Vengen OA; Knudsen CW; Husebye T; Pepper J; Lie M; Christensen G; Tønnessen T
    Eur J Heart Fail; 2008 Dec; 10(12):1201-7. PubMed ID: 18996047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.
    Xanthakis V; Larson MG; Wollert KC; Aragam J; Cheng S; Ho J; Coglianese E; Levy D; Colucci WS; Michael Felker G; Benjamin EJ; Januzzi JL; Wang TJ; Vasan RS
    J Am Heart Assoc; 2013 Nov; 2(6):e000399. PubMed ID: 24200688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
    Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients.
    González A; López B; Martín-Raymondi D; Lozano E; Varo N; Barba J; Serrano M; Díez J
    J Hypertens; 2005 Dec; 23(12):2297-304. PubMed ID: 16269972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of irbesartan on phenotypic alterations in monocytes and the inflammatory status of hypertensive patients with left ventricular hypertrophy.
    Zhang J; Yang L; Ding Y
    BMC Cardiovasc Disord; 2021 Apr; 21(1):194. PubMed ID: 33879070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects.
    Saglam M; Karakaya O; Esen AM; Barutcu I; Dogan S; Karavelioglu Y; Karapinar H; Akgun T; Esen O; Ozdemir N; Turkmen S; Kaymaz C
    Tohoku J Exp Med; 2006 Feb; 208(2):117-22. PubMed ID: 16434834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O; Inal V; Baysan O; Sağlam K
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
    Catena C; Verheyen ND; Url-Michitsch M; Kraigher-Krainer E; Colussi G; Pilz S; Tomaschitz A; Pieske B; Sechi LA
    Am J Hypertens; 2016 Mar; 29(3):303-10. PubMed ID: 26163660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
    Parrinello G; Licata A; Colomba D; Di Chiara T; Argano C; Bologna P; Corrao S; Avellone G; Scaglione R; Licata G
    J Hum Hypertens; 2005 Jul; 19(7):543-50. PubMed ID: 15944724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension.
    Ritter AM; de Faria AP; Barbaro N; Sabbatini AR; Corrêa NB; Brunelli V; Amorim R; Modolo R; Moreno H
    Blood Press; 2017 Apr; 26(2):122-129. PubMed ID: 27825280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between plasma microRNA-29a and left ventricular hypertrophy in patients with hypertension].
    Yao SY; Liu J; Li Y; Wang M; Wang C; Xue H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):215-220. PubMed ID: 30897881
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of serum transforming growth factor β
    Liu Y; Lin Y; Huang X; Li Y; Liu Y; Shi L
    Eur J Pediatr; 2023 Dec; 182(12):5439-5446. PubMed ID: 37755472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Serum Bilirubin and Left Ventricular Hypertrophy in Patients with Essential Hypertension.
    Zhou T; Chen X; Li Z; Li L
    PLoS One; 2015; 10(4):e0125275. PubMed ID: 25915415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among adiponectin, insulin resistance and atherosclerosis in non-diabetic hypertensive patients and healthy adults.
    Kou H; Deng J; Gao D; Song A; Han Z; Wei J; Jin X; Ma R; Zheng Q
    Clin Exp Hypertens; 2018; 40(7):656-663. PubMed ID: 29336612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.